Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)

Go back to Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)
Charming Shoppes (NASDAQ: CHRS) Delayed: 1.01 -0.04 (3.81%)
Previous Close $1.05    52 Week High $31.98 
Open $1.03    52 Week Low $12.04 
Day High $1.04    P/E N/A 
Day Low $0.99    EPS $-0.10 
Volume 641,450